A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects
NCT01474941
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
PF-04620110 or Placebo
DRUG:
PF-04620110 or Placebo
DRUG:
PF-04620110 or Placebo
Sponsor
Pfizer